{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T07:28:55Z","timestamp":1706772535653},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":8736,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1992,1]]},"DOI":"10.1111\/1523-1747.ep12494223","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T14:23:55Z","timestamp":1089901435000},"page":"50-54","source":"Crossref","is-referenced-by-count":38,"title":["Soluble Interleukin-2 Receptors Inhibit Interleukin 2-Dependent Proliferation and Cytotoxicity: Explanation for Diminished Natural Killer Cell Activity in Cutaneous T-Cell Lymphomas In Vivo?"],"prefix":"10.1016","volume":"98","author":[{"given":"Reinhard","family":"Dummer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Posseckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Nestle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Witzgall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen C","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Wiede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Sebald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Burg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12494223_bb0010","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1126\/science.6324343","article-title":"Production of an epidermal growth factor receptor-related protein","volume":"224","author":"Weber","year":"1984","journal-title":"Science"},{"key":"10.1111\/1523-1747.ep12494223_bb0015","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1084\/jem.158.3.752","article-title":"Spontaneous release of the Leu-2 (T8) molecule from human T cells","volume":"159","author":"Fujimoto","year":"1983","journal-title":"J Exp Med"},{"key":"10.1111\/1523-1747.ep12494223_bb0020","unstructured":"Becker JC, Dummer R, Burg G, Schmidt RE: Shedding of ICAM-1 from human melanoma cell lines induced by IFN-\u03b3 and TNF-\u03b1: functional consequences on cell mediated cytotoxicity (submitted)"},{"key":"10.1111\/1523-1747.ep12494223_bb0025","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro","volume":"135","author":"Rubin","year":"1985","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12494223_bb0030","first-page":"557","article-title":"Influence of soluble, interleukin-2 receptors and soluble CD 8 proteins on natural killer cell activity and clinical course in cutaneous T-cell lymphoma patients","volume":"8","author":"Dummer","year":"1990","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/1523-1747.ep12494223_bb0035","first-page":"386","article-title":"Soluble IL-2 receptor serum levels in cutaneous T-cell lymphoma: correlation with clinical stage and IL-2 receptor status in cutaneous infiltrates","volume":"91","author":"Kaudewitz","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12494223_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-00888-1","article-title":"Cutaneous lymphomas, pseudolymphomas and related disorders","author":"Burg","year":"1983"},{"key":"10.1111\/1523-1747.ep12494223_bb0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00205749","article-title":"Stage related decrease in natural killer cell activity in untreated patients with mycosis fungoides","volume":"18","author":"Levy","year":"1984","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/1523-1747.ep12494223_bb0050","first-page":"101","article-title":"Decreased natural killer cell activity in cutaneous T-cell lymphomas","volume":"306","author":"Laroche","year":"1983","journal-title":"New Engl J Med"},{"key":"10.1111\/1523-1747.ep12494223_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jlb.41.6.505","article-title":"Regulation of human large granular lymphocyte and T cell growth by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity","volume":"41","author":"Yamada","year":"1987","journal-title":"J Leuk Biol"},{"key":"10.1111\/1523-1747.ep12494223_bb0060","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.4049\/jimmunol.137.12.3841","article-title":"The released interleukin-2 receptor binds interleukin-2 efficiently","volume":"137","author":"Rubin","year":"1986","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12494223_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0022-1759(88)90015-4","article-title":"A competitive enzyme-linked immunoassay (ELISA) for the measurement of soluble human interleukin-2 receptors (IL-2R, Tac-protein)","volume":"107","author":"Goldstein","year":"1988","journal-title":"J Immunol Methods"},{"key":"10.1111\/1523-1747.ep12494223_bb0070","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4049\/jimmunol.120.6.2027","article-title":"T cell growth factor: parameters of production and a quantitative microassy for activity","volume":"120","author":"Gillis","year":"1978","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12494223_bb0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0022-1759(84)90477-0","article-title":"Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Application to detection of lymphokines and cell surface antigens","volume":"67","author":"Landgren","year":"1984","journal-title":"J Immunol Methods"},{"key":"10.1111\/1523-1747.ep12494223_bb0080","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.140.7.2249","article-title":"Structure-activity analysis of modified and truncated forms of the Tac receptor protein: site specific mutagenesis of Cysteine residues","volume":"140","author":"Rusk","year":"1988","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12494223_bb0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/311631a0","article-title":"Molecular cloning of cDNA encoding human IL-2 receptor","volume":"311","author":"Nikaido","year":"1984","journal-title":"Nature"},{"key":"10.1111\/1523-1747.ep12494223_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/eji.1830180115","article-title":"Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, 5 using modified cDNA expression vectors","volume":"18","author":"Karasuyama","year":"1988","journal-title":"Eur J Immunol"},{"key":"10.1111\/1523-1747.ep12494223_bb0095","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/MCB.7.8.2745","article-title":"High efficiency transformation of mammalian cells by plasmid DNA","volume":"7","author":"Chen","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1111\/1523-1747.ep12494223_bb0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1432-1033.1989.tb14647.x","article-title":"Mutant proteins of human Interleukin 2","volume":"180","author":"Weigel","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1111\/1523-1747.ep12494223_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-4347(00)83069-8","article-title":"Medium-scale ligand-affinity purification of two soluble forms of human IL-2 receptor","volume":"431","author":"Weber","year":"1988","journal-title":"J Chromatogr"},{"key":"10.1111\/1523-1747.ep12494223_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/1523-1747.ep12876139","article-title":"Purification of the IL-2 receptor (TAC) by ligand-affinity Chromatography and utilization of the immobilized receptor for receptor-affinity chromatography (RAC) purification of IL-2, mutant IL-2, and IL-2 fusion proteins","volume":"94","author":"Smart","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12494223_bb0115","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"10.1111\/1523-1747.ep12494223_bb0120","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.4049\/jimmunol.145.12.4131","article-title":"Identification of a soluble IL-2 receptor \u03b2-chain from human lymphoid cell line cells","volume":"145","author":"Honda","year":"1990","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12494223_bb0125","first-page":"1372","article-title":"Structural analysis of recombinant soluble human interleukin 2 receptor","volume":"54","author":"Miedei","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/1523-1747.ep12494223_bb0130","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.141.8.2612","article-title":"Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity, IL-1 and IL-2 inhibition","volume":"141","author":"Symons","year":"1988","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12494223_bb0135","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.154.5.1455","article-title":"T cell growth factor receptors: quantification, specifity and biological relevance","volume":"154","author":"Robb","year":"1981","journal-title":"J Exp Med"},{"key":"10.1111\/1523-1747.ep12494223_bb0140","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0021-9258(19)40049-5","article-title":"Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors","volume":"265","author":"Engelmann","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/1523-1747.ep12494223_bb0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.2139736","article-title":"Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor","volume":"248","author":"Fanslow","year":"1990","journal-title":"Science"},{"key":"10.1111\/1523-1747.ep12494223_bb0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(89)90295-X","article-title":"The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms","volume":"59","author":"Mosley","year":"1989","journal-title":"Cell"},{"key":"10.1111\/1523-1747.ep12494223_bb0155","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1200\/JCO.1987.5.8.1262","article-title":"Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: Correlation with survival","volume":"5","author":"Wagner","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1111\/1523-1747.ep12494223_bb0160","first-page":"320S","article-title":"The prognostic value of low pretreatment serum interleukin-2 receptor (sIL-2R) in patients with Hodgkin's disease (HD) (abstr)","volume":"116","author":"Gause","year":"1990","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/1523-1747.ep12494223_bb0165","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T-cell lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15593949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15593949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:20:30Z","timestamp":1682727630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15593949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992,1]]}},"alternative-id":["S0022202X15593949"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12494223","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1992,1]]}}}